Saint Lukes Hospital of Kansas City — Kansas City, Missouri

Saint Lukes Hospital of Kansas City is a clinical research site located in Kansas City, Missouri, United States 64111.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Saint Lukes Hospital of Kansas City has participated in 7 clinical trials with 3 currently active.

Therapeutic areas: Liver Fibrosis, Nonalcoholic Fatty Liver Disease (NAFLD), Nonalcoholic Steatohepatitis.

Sponsors: Bristol-Myers Squibb, Medtronic Cardiac Rhythm and Heart Failure, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Saint Lukes Hospital of Kansas City?

Saint Lukes Hospital of Kansas City has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Saint Lukes Hospital of Kansas City conducted?

Saint Lukes Hospital of Kansas City has 7 clinical trials on record, with 3 currently active. Their work covers Liver Fibrosis, Nonalcoholic Fatty Liver Disease (NAFLD), Nonalcoholic Steatohepatitis.

Is Saint Lukes Hospital of Kansas City accredited by Crixeo Health?

Yes — Saint Lukes Hospital of Kansas City holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Saint Lukes Hospital of Kansas City?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.